1.
Silverberg J, Irvine A, Foley P, Del Rosso J, Puig L, Stein Gold L, Dossenbach M, Casillas M, Gallo G, Akmaz B, Rand K. Comparative Efficacy of Lebrikizumab, Dupilumab, and Tralokinumab in Maintaining Treatment Response in Atopic Dermatitis at Varying Treatment Continuance Rates. J of Skin [Internet]. 2025Jan.13 [cited 2025Mar.13];9(1):s519. Available from: https://skin.dermsquared.com/skin/article/view/3158